ENTITY

Luye Pharma (2186 HK)

98

Analysis

Health Care • China

Luye Pharma Group Ltd focuses on the research and development, production, and sales of pharmaceutical drugs for orthopedics, neurology, gastroenterology, and hepatology. The Company also sells active ingredients, R&D results, and patents of new drugs, as well as providing research services on a contractual basis.

more

Refresh

Exchange Announcement • 11 Nov 2024 12:09

Voluntary Announcement - Approval Obtained For Class 1 Innovative Antidepressant Ly03021 For Clinical Trials In China

Exchange Announcement • 01 Nov 2024 22:30

Overseas Regulatory Announcement

Exchange Announcement • 30 Oct 2024 22:30

Completion Of The Issue Of Us$100,000,000 5.85 Per Cent. Convertible Bonds Due 2025

Exchange Announcement • 28 Oct 2024 22:30

Change Of Closing Date Of The Issue Of Us$100,000,000 5.85 Per Cent. Convertible Bonds Due 2025

Exchange Announcement • 23 Oct 2024 07:00

Proposed Issue Of Us$100,000,000 5.85 Per Cent. Convertible Bonds Due 2025 And Us$50,000,000 5.85 Per Cent. Convertible Bonds Due 2025

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5

x